Will Globus Medical stock go up?

According to Danelfin AI, Globus Medical has today an AI Score of 5/10 (Hold rating), because its probability of beating the market in 3 months (51.57%) is +0.75% vs. the average probability (50.82%) of all US-listed stocks.

What is the target price for Globus Medical stock?

The Globus Medical target price is $80.14 (1Y), according to the average price target offered by analysts.

Is it a good time to buy, sell, or hold Globus Medical stock right now?

Globus Medical has today a Hold rating (AI Score 5/10), according to Danelfin AI. Its probability of beating the market in 3 months (51.57%) is +0.75% vs. the average probability (50.82%) of all US-listed stocks, based on our AI-powered analysis. You can find more details on whether Globus Medical stock is a good buy .

Is Globus Medical undervalued right now?

Based on analysts, the average price target downside for Globus Medical is 0.00% (1Y). According to Danelfin AI, Globus Medical has today an AI Score of 5/10 (Hold Rating).

What was the price range of Globus Medical stock over the past 12 months?

The Globus Medical stock price range over the past 12 months has been $51.89 - $96.82.

What is going on with Globus Medical stock in the last 3 months?

The Globus Medical stock performance in the last quarter has been -8.66%.

Does Globus Medical offer dividend payments?

No, Globus Medical does not currently pay dividends.

What is the current market capitalization of Globus Medical?

Globus Medical's market cap is $10.87B, as of 2026-07-03 08:00.

Globus Medical Inc (GMED) AI Stock Analysis

Advanced Chart

Custom range

Jul 3, 2025

→

Jul 3, 2026

Custom range

Jul 3, 2025

→

Jul 3, 2026

GMED AI-Powered Stock Analysis

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

AI Score Explanation

Generating AI Score explanation

We're getting the explanation ready so you can easily understand what's behind the AI Score. This may take a few seconds.

Valuation+2.96%
How the stock is priced relative to its fundamentals
Size & Liquidity+0.15%
Company size and trading liquidity
Growth+0.15%
Expected pace of revenue and earnings expansion
Earnings Quality+0.07%
Stability and reliability of reported earnings

Sentiment-1.98%
How analysts and the market view the stock
Momentum-0.38%
Direction and strength of recent price movements
Volatility-0.22%
How much the stock price tends to fluctuate

GMED probability advantage of beating the market (3M):

+0.75%

AI Score

Hold

Globus Medical (GMED) has an AI Score of 5/10 (Hold) because, according to an overall analysis, it has a probability advantage of +0.75% of beating the market (S&P500) in the next 3 months. This advantage is calculated as the difference between the average probability of any US-listed stock (50.82%) and the probability of GMED (51.57%) of outperforming the market in the next 3 months, as determined by Danelfin AI’s comprehensive analysis.

Average probability of any US-listed stock of beating the market (3M)50.82%
GMED probability advantage of beating the market (3M)+0.75%
GMED probability of beating the market (3M)51.57%

GMED probability advantage of beating the market (3M): +0.75%

The AI-powered overall analysis of Globus Medical (GMED) is based on the 25 fundamental, technical, and sentiment features that had the greatest impact on stock performance during the last 12 months (alpha signals). These alpha signals explain the probability advantage of GMED:

Type	Alpha Signal	Current Value	Value Decile Position	Probability Advantage Impact (3M)
Fundamental	Fundamentals Impact (Long Tail)	-	N/A	+2.05%
Sentiment	Industry (GICS)	Health Care Equipment & Supplies	N/A	-1.79%
Technical	Chart Pattern (180d)	figure_187	N/A	-0.96%
Fundamental	Net Property, Plant & Equipment (Net PP&E)	557.14		+0.43%
Sentiment	Sentiment Impact (Long Tail)	-	N/A	-0.43%
Technical	Chart Pattern (90d)	figure_13	N/A	-0.38%
Technical	Chart Pattern (504d)	figure_4	N/A	+0.34%
Fundamental	Tangible Shareholders' Equity	2.57K		+0.30%
Sentiment	Earnings Countdown	-50		+0.27%
Fundamental	Operating Cash Flow (Qtr Discrete)	202.36		+0.27%
Sentiment	Upgrade to unlock			-0.25%
Technical	Upgrade to unlock			-0.22%
Fundamental	Upgrade to unlock			-0.20%
Technical	Upgrade to unlock			-0.19%
Sentiment	Upgrade to unlock			+0.19%

Rest of Alpha Signals: +1.30%

GMED probability advantage of beating the market (3M)Total:+0.75%
GMED AI Score

Significant changes Vs previous day

GMED Trading Parameters

These suggested trading parameters for a 3-month horizon help improve risk management and decision-making.

Entry:$80.14
Horizon: 3 months
Stop Loss:$XXXXXPro (XXXXXPro) or AI Score < 4/10
Take Profit:$XXXXXPro (XXXXX
Pro
) or AI Score < 4/10

GMED Proven Hold Signal & Price Forecast

This is the price chart for GMED from January 2, 2026 until today. The chart indicates, in yellow, the 112 days when the stock received a Hold rating (hold signals, AI Score 4 to 6).

Forecast: In the section below, the central dotted line represents the most expected path, while the shaded area indicates the anticipated price range. This is based on previous Hold signals with a 90% confidence level.

Full Track Record

Unlock AI-powered forecast

Closing price (USD)
Hold signals

Forecast:

1 Month
3 Months
6 Months
1 Year

GMED Average Past Performance & Win Rate

Three months after its 1572 Hold signals since July 2026, GMED had an average performance of xxxxxx and a xxxxxx Win rate (positive performance).

1572 Past GMED Hold Signals	1 Month Later	3 Months Later	6 Months Later	1 Year Later
Average Performance				+12.69%
Average Alpha				+0.01%
Win Rate (% Positive Perf.)				58.37%
% Positive Alpha				41.09%

GMED Frequently Asked Questions

Will Globus Medical stock go up?
According to Danelfin AI, Globus Medical has today an AI Score of 5/10 (Hold rating), because its probability of beating the market in 3 months (51.57%) is +0.75% vs. the average probability (50.82%) of all US-listed stocks.
What is the target price for Globus Medical stock?
Is it a good time to buy, sell, or hold Globus Medical stock right now?
Is Globus Medical undervalued right now?
What was the price range of Globus Medical stock over the past 12 months?
What is going on with Globus Medical stock in the last 3 months?
Does Globus Medical offer dividend payments?
What is the current market capitalization of Globus Medical?

Globus Medical Inc Company Profile

Globus Medical, Inc. is a prominent player in the field of medical technology that specializes in curating advanced healthcare solutions for patients who face musculoskeletal disorders. The company's area of operation spans both domestic and international markets. Its comprehensive portfolio includes specially-designed spine products such as pedicle screw and rod systems, plating systems, intervertebral spacers, to treat a wide range of conditions including degenerative diseases, congenital anomalies, tumors and trauma-associated injuries.

In addition to this, the corporation provides alternative treatment channels focusing on innovative motion-preservation technologies like dynamic stabilization elements, total disc replacements, along with interspinous distraction devices. Furthermore, it offers interventional equipment to tackle vertebral compression fractures.

Another vital facet of its offerings includes biological resources aimed at promoting regeneration; these encompass allografts and synthetic alternatives. Moreover, for addressing orthopedic trauma cases, Globus Medical puts forth an array of devices like fracture plates or compression screws as well as intramedullary nails and external fixation methods.

Globus Medical's inventory also accommodates hip and knee joint solutions such as modular hip stems or acetabular cups besides posterior stabilizing and cruciate withholding knee arthroplasty components. For enhancing patient care through regenerative medicine practices, the company takes part in distributing human cell-based products along with tissue-derived substitutes.

Its distribution strategy involves selling its products through a mix of direct sales representatives or distributors alongside independent sales agents specializing in hip and knee product ranges. Initiated into the business world in 2003, Globus Medical has anchored its headquarters within Audubon’s business nucleus situated in Pennsylvania.

Sector:Health Care
Country:United States
Industry:Health Care Equipment & Supplies
Address:2560 General Armistead Ave, Audubon
Employees:6,000
Website:globusmedical.com

Pros

High switching costs for trained surgeons

Aging global population driving procedure demand

Proprietary intellectual property in surgical robotics

Recurring revenue from consumable implant sales

Expansion into adjacent orthopedic markets

Cons

Intense competition from established medical device firms

Regulatory hurdles for new product approvals

Reimbursement pressure from healthcare payers

Capital intensity of research and development

Dependence on surgeon adoption and training

Pros

Cons

Company

AI Score

Compare

BMGLBasel Medical Group Ltd

BSXBoston Scientific Corp

OFIXOrthofix Medical Inc

GKOSGlaukos Corp

Company

AI Score

Compare

GMED Top 10 Industry Stocks

Health Care Equipment & Supplies

	Company	AI Score	Compare
1	UTMDUtah Medical Products Inc
2	CVRXCVRx Inc
3	PODDInsulet Corp
4	ADGMAdagio Medical Holdings Inc
5	XTNTXtant Medical Holdings Inc
6	TMDXTransmedics Group Inc
7	GUTSFractyl Health Inc
8	PDEXPro-Dex Inc
9	PHGKoninklijke Philips NV
10	ALCAlcon AG

	Company	AI Score	Compare

	Company	AI Score	Compare
1	COGTCogent Biosciences Inc

Company

AI Score

Compare

COGTCogent Biosciences Inc

Company

AI Score

Compare

GMED Stock AI Analysis